This announcement is a separate document:
康龍化成：2021年度董事會及監事會工作報告；2021年度財務決算報告；2021年度利潤分配預案；建議授出發行額外換股股份的可轉換債券相關特別授權；2021年年度報告全文、報告摘要及2021年年度業績公告；2022年度董事及監事薪酬；委聘2022年度境內及
Pharmaron Beijing Co., Ltd.*: REPORT OF BOARD & SUPERVISORY COMMITTEE;FINANCIAL STATEMENTS;PROFIT DISTRIBUTION PLAN;GRANT OF CONVERTIBLE BONDS-RELATED SPECIFIC MANDATE;REPORT & ANNUAL RESULTS ANNOUNCEMENT;REMUNERATION OF DIRECTORS & SUPERVISORS;ENGAGEMENT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.